l-Carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor-α levels in patients with type 2 diabetes: a double-blind placebo-controlled randomized clinical trial.
- 2018-01
- RCT · n = 54
- Nutrition research (New York, N.Y.) 49
- Shiva Houjeghani
- Sorayya Kheirouri
- Esmaeil Faraji
- Mohammad Asghari Jafarabadi
- PubMed: 29420997
- DOI: 10.1016/j.nutres.2017.11.003
- High evidence
- Clinical
No significant differences were observed in ... diastolic blood pressure
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 2 capsules of l-carnosine 500 mg each (1000 mg/day)